My Portfolio
My Watchlists
Profile & Performance
Smart Portfolio
Find & Follow Experts
Top Lists
Top Experts
Make Better, Data Driven Investment Decisions
TipRanks tools are all you need to make data-driven investment decisions, conduct comprehensive stock research, find new investment ideas, analyze your portfolio, and follow the best-performing Wall Street experts.
About Us
Plans & Pricing
Guardant Health (GH)
GH nasdaq
United States
Guardant Health

Guardant Health Stock Analysis & Ratings

Guardant Health Stock Analysis Overview

Smart Score
Learn more about TipRanks Smart Score
The Guardant Health stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.

Stock Chart


GH Stock Stats

Previous Close$104.24
Bid0 x 0
Ask0 x 0
Today’s Range$101 - $105.2039
52-Week Range$96.66 - $181.07
Average Volume925.28K
Market Cap$10.29B
P/E Ratio-26.9
Earnings DateNov 04, 2021

Company Description

Guardant Health

Guardant Health, Inc. is a precision oncology company, which engages in provision of precision oncology testing and development services. It focuses performing blood tests, vast data sets, and advanced analytics to conquer cancer. The company was founded by Helmy Eltoukhy and AmirAli H. Talasaz in 2012 and is headquartered in Redwood City, CA.
Medical Diagnostics & Research
Helmy Eltoukhy / AmirAli Talasaz
505 Penobscot Drive, Redwood City, CA, 94063, US


P/E Ratio Range

The price to earnings ratio. This is used by investors to assess a stock’s market price relative to its earnings.


What was Guardant Health’s price range in the past 12 months?
Guardant Health lowest stock price was $96.66 and its highest was $181.07 in the past 12 months.
    What is Guardant Health’s market cap?
    Guardant Health’s market cap is $10.29B.
      What is Guardant Health’s price target?
      The average price target for Guardant Health is $176.67. This is based on 3 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
      The highest analyst price target is $180.00 ,the lowest forecast is $170.00. The average price target represents 73.89% Increase from the current price of $101.6.
        What do analysts say about Guardant Health?
        Guardant Health’s analyst rating consensus is a ‘Strong Buy. This is based on the ratings of 3 Wall Streets Analysts.
          When is Guardant Health’s upcoming earnings report date?
          Guardant Health’s upcoming earnings report date is Nov 04, 2021 which is in 18 days.
            How were Guardant Health’s earnings last quarter?
            Guardant Health released its earnings results on Aug 05, 2021. The company reported -$0.964 earnings per share for the quarter, missing the consensus estimate of -$0.819 by -$0.145.
              Is Guardant Health overvalued?
              According to Wall Street analysts Guardant Health’s price is currently Undervalued.
                Does Guardant Health pay dividends?
                Guardant Health does not currently pay dividends.
                What is Guardant Health’s EPS estimate?
                Guardant Health’s EPS estimate for its next earnings report is not yet available.
                How many shares outstanding does Guardant Health have?
                Guardant Health has 101,300,000 shares outstanding.
                  What happened to Guardant Health’s price movement after its last earnings report?
                  Guardant Health reported an EPS of -$0.964 in its last earnings report, missing expectations of -$0.819. Following the earnings report the stock price went up 0.184%.
                    Which hedge fund is a major shareholder of Guardant Health?
                    Among the largest hedge funds holding Guardant Health’s share is Coatue Management, LLC. It holds Guardant Health’s shares valued at 330M.

                      What's Included in PREMIUM?
                      Make informed decisions based on Top Analysts' activity
                      Know what industry insiders are buying
                      Get actionable alerts from top Wall Street Analysts
                      Find out before anyone else which stock is going to shoot up
                      Get powerful stock screeners & detailed portfolio analysis